Gardiquimod (Standard)

Gardiquimod (Standard) is the analytical standard of Gardiquimod. This product is intended for research and analytical applications. Gardiquimod is an imidazoline TLR7/8 agonist. Gardiquimod inhibits HIV-1 infection of macrophages and activated peripheral blood mononuclear cells (PBMCs) . Gardiquimod specifically activates TLR7 at concentrations below 10 μM.

Product Specifications

CAS Number

[1020412-43-4]

UNSPSC

12352005

Target

Reference Standards; Toll-like Receptor (TLR)

Related Pathways

Immunology/Inflammation; Others

Field of Research

Cancer

Smiles

OC(C)(C)CN1C(CNCC)=NC2=C1C3=CC=CC=C3N=C2N

Molecular Formula

C17H23N5O

Molecular Weight

313.40

References & Citations

[1]Buitendijk M, et al. Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells. AIDS Res Hum Retroviruses. 2013 Jun;29 (6) :907-18.|[2]Zhou Z, et al. TLR7/8 agonists promote NK-DC cross-talk to enhance NK cell anti-tumor effects in hepatocellular carcinoma. Cancer Lett. 2015 Dec 28;369 (2) :298-306.